Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.66 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.66 |
| ▸ | MGLL | Q99685 | 1/20 | 0.64 |
| ▸ | DGKA | P23743 | 1/20 | 0.61 |
| ▸ | FAAH | O00519 | 4/20 | 0.58 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.55 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.52 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.52 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.52 |
| ▸ | PRKCA | P17252 | 1/20 | 0.52 |
| ▸ | LPAR1 | Q92633 | 7/20 | 0.52 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.52 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.52 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.52 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.52 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.52 |
| ▸ | CES2 | O00748 | 1/20 | 0.52 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.52 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27513328 | 1.00 | FFAR1 (0.66) | FFAR1FFAR4MGLLDGKAFAAH | |
| Ethylene Glycol SCHEMBL5162980 | 0.95 | FFAR1 (0.66) | FFAR1FFAR4MGLLDGKAFAAH | |
| Sulfuric Acid SCHEMBL28597645 | 0.94 | FFAR1 (0.59) | FFAR1FFAR4MGLLDGKAFAAH | |
| SCHEMBL12836601 | 0.94 | FFAR1 (0.64) | FFAR1FFAR4MGLLDGKAFAAH | |
| SCHEMBL3460445 | 0.94 | FFAR1 (0.64) | FFAR1FFAR4MGLLDGKAFAAH | |
| SCHEMBL30775153 | 0.94 | FFAR1 (0.71) | FFAR1FFAR4MGLLDGKAFAAH | |
| SCHEMBL26868705 | 0.94 | FFAR1 (0.71) | FFAR1FFAR4MGLLDGKAFAAH | |
| SCHEMBL17451093 | 0.93 | EPHX2 (0.65) | FFAR1FFAR4MGLLDGKAFAAH | |
| SCHEMBL2066896 | 0.93 | EPHX2 (0.65) | FFAR1FFAR4MGLLDGKAFAAH | |
| SCHEMBL12842107 | 0.93 | FFAR1 (0.63) | FFAR1FFAR4MGLLDGKAFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 905 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4734923-A1 | CLEANSING COMPOSITIONS COMPRISING DIVALENT SALTS | L'OREAL (FR) | 2026-05-06 | — | — | EP | claimed |
| US-20250275894-A1 | STABLE FOAMED CLEANSING COMPOSITION AND METHODS OF USE | L'OREAL (FR) | 2025-09-04 | — | — | US | claimed |
| CN-119842357-A | Anti-aging low-temperature-resistant glue and preparation method and application thereof | 广州华广新材料科技有限公司 | 2025-04-18 | — | — | CN | claimed |
| CN-116375396-B | Self-cleaning rock slice real stone paint and preparation method thereof | 天津德普威涂料有限公司 | 2025-01-24 | — | — | CN | claimed |
| US-20250009628-A1 | CLEANSING COMPOSITIONS COMPRISING DIVALENT SALTS | L'OREAL (FR) | 2025-01-09 | — | — | US | claimed |
| WO-2025006412-A1 | CLEANSING COMPOSITIONS COMPRISING DIVALENT SALTS | L'OREAL (FR) | 2025-01-02 | — | — | WO | claimed |
| CN-117777902-A | Bio-based acrylate pressure-sensitive adhesive and preparation method thereof | 厦门纬达树脂有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-114767606-B | Crystal dew capable of instantly dissolving water and preparation method thereof | 广东博然堂生物科技有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-116904019-A | Modified glass fiber reinforced nylon composite material and preparation method thereof | 福建师范大学泉港石化研究院 | 2023-10-20 | — | — | CN | claimed |
| US-20230248672-A1 | COMPOSITIONS COMPRISING GARDOS CHANNEL ANTAGONISTS AND THEIR USES | ADIMABIO LLC (US) | 2023-08-10 | — | — | US | claimed |
| US-5952517-A | BY HIGH TEMPERATURE CAUSTIC OXIDATION, USING A DILUENT, CATALYST TO CAUSE PYROLYSIS; CHEMICAL INTERMEDIATES; POLYHEXAMETHYLENE SEBACAMIDE | CASCHEM, INC. (US) | 1999-09-14 | — | — | US | claimed |
| WO-1998035925-A1 | METHOD FOR PREPARING CLEAVED PRODUCTS FROM CASTOR OIL OR DERIVATIVES THEREOF | CASCHEM, INC. (US) | 1998-08-20 | — | — | WO | claimed |
| US-5795695-A | PHOTO-QUALITY RECORDING | XEROX CORPORATION (US) | 1998-08-18 | — | — | US | claimed |
| EP-0444178-A4 | MASCARA COMPOSITION | — | 1992-07-08 | — | — | EP | claimed |
| EP-0444178-A1 | MASCARA COMPOSITION | REVLON, INC. (US) | 1991-09-04 | — | — | EP | claimed |
| WO-1991004006-A1 | MASCARA COMPOSITION | REVLON, INC. (US) | 1991-04-04 | — | — | WO | claimed |
| US-4988502-A | Cosmetics, pigments treated with lecithin, film forming resin, a humectant | REVLON, INC. (US) | 1991-01-29 | — | — | US | claimed |
| EP-0122624-B1 | MICROPARTICLES AND ULTRASONIC CONTRAST MEANS CONTAINING GAS BUBBLES | SCHERING AKTIENGESELLSCHAFT (DE) | 1988-09-07 | — | — | EP | claimed |
| US-4578401-A | Mental complexes having an antineoplastic action, and medicaments containing these complexes | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1986-03-25 | — | — | US | claimed |
| WO-1983000868-A1 | METAL COMPLEXES HAVING AN ANTINEOPLASTIC ACTION, AND MEDICAMENTS CONTAINING THESE COMPLEXES | KELLER, HEIMO, J. | 1983-03-17 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250275894-A1 | STABLE FOAMED CLEANSING COMPOSITION AND METHODS OF USE | DAGLB, MGLL, LIPC | FFAR1 493/4885FFAR4 1041/4885MGLL 2/4885 |
| US-20250009628-A1 | CLEANSING COMPOSITIONS COMPRISING DIVALENT SALTS | DAGLB, DSG1, CUTA | FFAR1 1770/4885FFAR4 2644/4885MGLL 7/4885 |
| US-20230248672-A1 | COMPOSITIONS COMPRISING GARDOS CHANNEL ANTAGONISTS AND THEIR USES | CACNA1G, CACNA1I, CACNG2 | FFAR1 2235/4885FFAR4 2159/4885MGLL 2094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.